July 2021

Piramal Healthcare Limited A major force in the pharmaceuticals and healthcare segment, Piramal Healthcare Limited, incorporating Healthcare Solutions & Pharma Solutions, has an unequivocal vision – to become the most admired pharmaceutical company, with leadership in market share and profits.

Post : Research Associate - R&D

Hetero is a globally renowned vertically integrated pharmaceutical player engaged in research and development, manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas. Backed by 27 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, Global Generics, Biosimilars and Custom Pharmaceutical Services. The company is among the largest producers of Active Pharmaceutical Ingredients in the world.

CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) is a constituent laboratory of Council of Scientific and Industrial Research (CSIR), which is an autonomous body under the Ministry of Science & Technology, Government of India. The Institute conducts research in all frontline areas of Biological, Agricultural & Chemical Sciences.

Harman finochem limited is a leading manufacturer of "active pharmaceutical ingredients" situated in Mumbai, India, exporting api globally. The manufacturing facilities comply to cgmp requirements and have been audited by usfda and who Gmp. Besides this, the company has also been accredited by various other regulatory authorities such as cos from edqm, pharmaceutical inspection convention (pic) member countries, tga-Australia.

The World Health Organization (WHO) has updated its patient care guidelines to include interleukin-6 receptor blockers, a class of medicines that are lifesaving in patients who are severely or critically ill with COVID-19, especially when administered alongside corticosteroids.

These were the findings from a prospective and a living network meta-analysis initiated by WHO, the largest such analysis on the drugs to date. Data from over 10 000 patients enrolled in 27 clinical trials were considered.

Amgen announced that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) and granted Priority Review for tezepelumab in the treatment of asthma. Tezepelumab is being developed by Amgen in collaboration with AstraZeneca.

The National Institute of Epidemiology (NIE) was established on July 2, 1999 by merging the Central JALMA Institute for Leprosy (CJIL Field Unit), Avadi with the Institute for Research in Medical Statistics (IRMS), Chennai. The broad objectives of the Institute cover Development of human resources in epidemiology and bio-statistics, Networking of the various ICMR and non-ICMR Institutes at the national level for epidemiological purposes, and Consultancy.

Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) can trace its origins to the Ecole de Medicine de Pondicherry established by the French Government in 1823. In 1956 foundation for new medical college was laid and in 1964, hospital was inaugurated. JIPMER became an institution of national importance under the Ministry of Health and Family Welfare, Government of India in the year 2008. It is an institution established for teaching, research and patient care in the area of health. JIPMER spreads over 192 acres.

The Central Council for Research in Ayurvedic Sciences (CCRAS) is an autonomous body of the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy), Government of India. It is an apex body in India for the formulation, coordination, development and promotion of research on scientific lines in Ayurveda and Sowa-Rigpa system of medicine.